Showing results (51-60 of 107) with videos related to

Sort By:
Pageof 11
Oncotarget|October 21, 2017
Targeting MUC1-C suppresses polycomb repressive complex 1 in multiple myelomaAshujit Tagde, Tahireh Markert, Hasan Rajabi, et al.
British Journal of Haematology|May 27, 2005
Fusion of dendritic cells with multiple myeloma cells results in maturation and enhanced antigen presentationBaldev Vasir, Virginia Borges, Zekui Wu, et al.
Mediterranean Journal of Hematology and Infectious Diseases|March 19, 2011
The treatment of multiple myeloma patients not eligible for asctPaul Richardson, Jacob Laubach, Anuj Mahindra, et al.
British Journal of Haematology|February 21, 2006
FQPD, a novel immunomodulatory drug, has significant in vitro activity in multiple myelomaShaji Kumar, Noopur Raje, Teru Hideshima, et al.
Blood|February 25, 2016
MUC1-C drives MYC in multiple myelomaAshujit Tagde, Hasan Rajabi, Audrey Bouillez, et al.
Scientific Reports|December 31, 2024
Wild Andean camelids promote rapid ecosystem development after glacier retreatKelsey E Reider, Clifton P Bueno de Mesquita, Kenneth Anderson, et al.
Oncotarget|October 15, 2017
Melflufen - a peptidase-potentiated alkylating agent in clinical trialsMalin Wickström, Peter Nygren, Rolf Larsson, et al.
Cancer Chemotherapy and Pharmacology|April 17, 2013
The interaction of bortezomib with multidrug transporters: implications for therapeutic applications in advanced multiple myeloma and other neoplasiasRobert O'Connor, Melissa G Ooi, Justine Meiller, et al.
Blood|March 14, 2019
A phase 1b study of isatuximab plus pomalidomide/dexamethasone in relapsed/refractory multiple myelomaJoseph Mikhael, Paul Richardson, Saad Z Usmani, et al.
American Journal of Hematology|May 15, 2024
Three-dimensional telomere profiling predicts risk of progression in smoldering multiple myelomaShaji Kumar, S Vincent Rajkumar, Dragan Jevremovic, et al.
Pageof 11